Catalyst Pharm Inc (CPRX)

Mar 26, 2025, 8:12 AM EDT - 8 days ago

Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 11, 2025, 4:05 AM EDT - 23 days ago

Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts

Mar 4, 2025, 8:03 AM EST - 4 weeks ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Mar 3, 2025, 2:39 PM EST - 4 weeks ago

Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges

Feb 27, 2025, 12:29 PM EST - 5 weeks ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:13 PM EST - 5 weeks ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 12, 2025, 8:03 AM EST - 7 weeks ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Feb 7, 2025, 3:56 PM EST - 7 weeks ago

Catalyst Remains a Big Money Favorite

Jan 23, 2025, 8:03 AM EST - 2 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Jan 21, 2025, 8:19 AM EST - 2 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

Jan 13, 2025, 8:30 AM EST - 2 months ago

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

Jan 8, 2025, 12:30 PM EST - 3 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

Dec 16, 2024, 8:03 AM EST - 3 months ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 25, 2024, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

Nov 19, 2024, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Nov 13, 2024, 8:03 AM EST - 5 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Nov 7, 2024, 10:34 AM EST - 5 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:12 PM EST - 5 months ago

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 22, 2024, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

Oct 8, 2024, 8:03 AM EDT - 6 months ago

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

Oct 1, 2024, 8:03 AM EDT - 6 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

Sep 24, 2024, 6:00 AM EDT - 6 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

Sep 12, 2024, 1:00 AM EDT - 7 months ago

Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 8:35 AM EDT - 8 months ago

Top 3 Health Care Stocks That May Crash In August

CAH VRNA

Aug 8, 2024, 1:30 PM EDT - 8 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:11 PM EDT - 8 months ago

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

Jul 30, 2024, 10:13 AM EDT - 8 months ago

Top 3 Health Care Stocks You May Want To Dump This Quarter

VRDN VRNA

Jul 24, 2024, 8:05 AM EDT - 9 months ago

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

Jul 22, 2024, 8:03 AM EDT - 9 months ago

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 17, 2024, 11:57 AM EDT - 9 months ago

These small-cap stocks score highest when screened for quality

CALX CARG CORT GOGO MC MYRG PLMR

May 30, 2024, 1:41 PM EDT - 11 months ago

Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®

May 28, 2024, 8:03 AM EDT - 11 months ago

Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024

May 9, 2024, 10:52 AM EDT - 11 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:16 PM EDT - 11 months ago

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

Apr 25, 2024, 1:00 AM EDT - 1 year ago

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Apr 22, 2024, 8:00 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 5, 2024, 8:29 PM EDT - 1 year ago

Jim Cramer lays out his top small-cap healthcare picks

ADUS ITGR OMI PGNY

Apr 5, 2024, 6:51 PM EDT - 1 year ago

Jim Cramer recommends five small-cap health-care stocks

ADUS ITGR OMI PGNY

Mar 28, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

Mar 27, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

Mar 14, 2024, 2:00 AM EDT - 1 year ago

Santhera's Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States

Mar 13, 2024, 7:55 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

Mar 5, 2024, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference

Feb 29, 2024, 11:32 AM EST - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 6:03 PM EST - 1 year ago

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 27, 2024, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE

Feb 21, 2024, 9:00 AM EST - 1 year ago

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical's VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology

Feb 14, 2024, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Jan 9, 2024, 4:05 PM EST - 1 year ago

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering

Jan 5, 2024, 8:02 AM EST - 1 year ago

Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock